June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
New Ophthalmic Viscosurgical Device (OVD) with Enhanced Hydroxyl Radical Scavenging Activity
Author Affiliations & Notes
  • William Joseph Erb
    Bausch and Lomb Rochester, Rochester, New York, United States
    Bausch Health Companies Inc, Laval, Quebec, Canada
  • Madhu Ayyagari
    Bausch Health Companies Inc, Laval, Quebec, Canada
  • George Lau
    Bausch Health Companies Inc, Laval, Quebec, Canada
  • Footnotes
    Commercial Relationships   William Erb, None; Madhu Ayyagari, None; George Lau, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 598. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      William Joseph Erb, Madhu Ayyagari, George Lau; New Ophthalmic Viscosurgical Device (OVD) with Enhanced Hydroxyl Radical Scavenging Activity. Invest. Ophthalmol. Vis. Sci. 2021;62(8):598.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In-vitro evaluation of increased hydroxyl radical scavenging activity of a new dispersive ophthalmic viscosurgical device (ClearVisc OVD, Bausch and Lomb, Inc.).

Methods : Using the 2-deoxy-D-ribose oxidation method, hydroxyl radicals (OH) are formed for detection via high-performance liquid chromatography (HPLC) with UV detection. Various OVD components such as buffer and additives as well as other OVD formulations have been utilized to measure their ability to scavenge free radicals that are typically formed during phacoemulsification.

Results : The results of testing provide a comparison of water as control as well as standard sodium hyaluronate formulations to the ClearVisc OVD. The results show the effectiveness of the new buffer and sorbitol additive capabilities to scavenge free radicals.

Conclusions : Hydroxyl free radicals generated during phacoemulsification in cataract surgery can contribute to corneal endothelial damage. The overall results in this study show the effectiveness of the combination of buffer and additives in this new dispersive OVD in hydroxyl free radical inhibition.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×